ES2163419T3 - Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno. - Google Patents

Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno.

Info

Publication number
ES2163419T3
ES2163419T3 ES94118662T ES94118662T ES2163419T3 ES 2163419 T3 ES2163419 T3 ES 2163419T3 ES 94118662 T ES94118662 T ES 94118662T ES 94118662 T ES94118662 T ES 94118662T ES 2163419 T3 ES2163419 T3 ES 2163419T3
Authority
ES
Spain
Prior art keywords
treatment
nitrogen metabolism
compsns
nutritive compositions
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94118662T
Other languages
English (en)
Inventor
Dave C Madsen
David A Mark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Application granted granted Critical
Publication of ES2163419T3 publication Critical patent/ES2163419T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

SE PREVE UNA COMPOSICION NUTRITIVA QUE ES BAJA EN AMONIAGENICOS RECOGE AMONIACO, Y NO CONTRIBUYEN A LA PRODUCCION DE OXIDO NITRICO EXCESIVO. LA COMPOSICION NUTRITIVA COMPRENDE UN PERFIL DE AMINOACIDO QUE TIENE MENOS DE 20% DE LOS AMINOACIDOS TOTALES COMO AMINOACIDOS AMONIAGENICOS. LA COMPOSICION NUTRITIVA COMPRENDE TAMBIEN MENOS DE 0.2% DE LOS AMINOACIDOS TOTALES COMO ARGININA Y AL MENOS 0.2% DE LOS AMINOACIDOS TOTALES COMO ORNITINA Y CITRULINA.
ES94118662T 1993-12-03 1994-11-28 Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno. Expired - Lifetime ES2163419T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/161,917 US5378722A (en) 1993-12-03 1993-12-03 Nutritional compositions for management of nitrogen metabolism

Publications (1)

Publication Number Publication Date
ES2163419T3 true ES2163419T3 (es) 2002-02-01

Family

ID=22583360

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94118662T Expired - Lifetime ES2163419T3 (es) 1993-12-03 1994-11-28 Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno.

Country Status (8)

Country Link
US (1) US5378722A (es)
EP (1) EP0656178B1 (es)
AT (1) ATE206587T1 (es)
CA (1) CA2136569A1 (es)
DE (1) DE69428575T2 (es)
DK (1) DK0656178T3 (es)
ES (1) ES2163419T3 (es)
PT (1) PT656178E (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728678A (en) * 1995-06-06 1998-03-17 Nestec Ltd. Method and composition for providing nutrition to a renal failure patient
AU4280600A (en) * 1999-04-27 2000-11-10 International Health Products And Services Ltd. Supplement for restoring growth hormone levels
CA2401383A1 (en) * 2001-02-14 2002-08-22 Matthias Rath Compositions of biochemical compounds involved in bioenergy metabolism of cells and method of use
FR2857262B1 (fr) * 2003-07-08 2007-10-05 Biocodex Lab Utilisation de la citrulline dans le cadre de l'insuffisance intestinale
EP2032697A1 (en) * 2006-06-26 2009-03-11 DSMIP Assets B.V. Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides
JPWO2013129642A1 (ja) * 2012-03-02 2015-07-30 協和発酵バイオ株式会社 摂食活動および／または消化管活動促進剤
EP2745707A1 (en) * 2012-12-20 2014-06-25 Promo Pharma S.p.A. A nutraceutical compound
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2019036471A1 (en) 2017-08-14 2019-02-21 Axcella Health Inc. AMINO ACIDS BRANCHED FOR THE TREATMENT OF LIVER DISEASE
JP2021527670A (ja) 2018-06-20 2021-10-14 アクセラ・ヘルス・インコーポレイテッドＡｘｃｅｌｌａ Ｈｅａｌｔｈ Ｉｎｃ． 筋肉中の脂肪浸潤の治療のための組成物及び方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2038163A1 (de) * 1969-08-07 1971-02-25 Kyowa Hakko Kogyo Kk Wasserunloeslichmachen basischer Aminosaeuren
US4340592A (en) * 1980-03-14 1982-07-20 Adibi Siamak A Nutrient compositions and method of administering the same
DE3583852D1 (de) * 1984-11-19 1991-09-26 Montefiore Hospital Ass Of Wes Naehrstoffzusammensetzungen.
US5034377A (en) * 1984-11-19 1991-07-23 Montefiore Hospital Association Of Western Pennsylvania Aqueous nutrient compositions comprising oligopeptides
WO1987003806A1 (en) * 1985-12-18 1987-07-02 Veech Richard L Parenteral nutrition therapy with amino acids
US4988724A (en) * 1988-12-09 1991-01-29 Board Of Regents, The University Of Texas System Methods and improved formulations for the determination and treatment of malignant disease in patients
US5356873A (en) * 1992-11-05 1994-10-18 Clintec Nutrition Co. Method for providing nutritional requirements to patients having a chronic inflammation reaction

Also Published As

Publication number Publication date
US5378722A (en) 1995-01-03
EP0656178A3 (en) 1995-07-26
EP0656178A2 (en) 1995-06-07
DE69428575D1 (de) 2001-11-15
EP0656178B1 (en) 2001-10-10
CA2136569A1 (en) 1995-06-04
DK0656178T3 (da) 2001-11-05
PT656178E (pt) 2002-02-28
DE69428575T2 (de) 2002-05-29
ATE206587T1 (de) 2001-10-15

Similar Documents

Publication Publication Date Title
Wykes et al. Chronic low protein intake reduces tissue protein synthesis in a pig model of protein malnutrition
WO2002039978A8 (de) Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten
PT944396E (pt) Composicoes e processos para melhorar o funcionamento gastrointestinal
ZA867387B (en) Pharmaceutical and dietary composition
ES2163419T3 (es) Composiciones nutritivas para el tratamiento del metabolismo del nitrogeno.
CY1108033T1 (el) Βελτιωμενη παιδιατρικη συνθεση και μεθοδοι για την παροχη τροφης και τη βελτιωση της ανεκτικοτητος
PT614616E (pt) Composicao para o tratamento de pacientes com doenca hepatica
DE69806820D1 (de) Kaloriereiche ernährungszusammensetzung
NO973884D0 (no) Aminosyrepreparater og anvendelse derav for klinisk ernæring
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
ATE216234T1 (de) Zusammensetzungen aus aminosäure zur behandlung von infektionen
GB8311804D0 (en) Treatment of seizure disorders and pharmaceutical compositions
ES2157208T3 (es) Composicion y procedimiento para la reduccion del riesgo de hipotension.
Waterhouse et al. Free amino acid levels in the blood of patients undergoing parenteral alimentation
NZ336043A (en) Use of COMT inhibitors for preventing diabetic vascular dysfunctions or neuropathy
AU9280298A (en) Remedy for hepatopathy
Dryden et al. Vitamin B12 deficiency in the rat fed high protein rations
Watford Is there a requirement for glutamine catabolism in the small intestine?
Wu et al. Cytotoxic activity of FK973 against human oral and breast cancer cells
Mirtallo A key to the literature of total parenteral nutrition
Andersen et al. Effects of DDC and related compounds on cadmium toxicokinetics
Wurtman et al. General discussion: calculation of the aspartame dose for rodents that produces neurochemical effects comparable to those occurring in people
Masanés et al. Absorption of a protein gavage in Zucker lean rats. Influence of protein content in the diet
Naka et al. Improved protein metabolism by TPN supplemented with alanyl-glutamine in protracted bacterial peritonitis

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 656178

Country of ref document: ES